SCHEMBL2642140

SCHEMBL2642140

CS(=O)(=O)c1ccc([C@H](CC(=O)Nc2ccc(Cl)cn2)C2CCC(=O)CC2)cc1Cl

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ GCK P35557 3/20 0.48
▸ HTT P42858 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ KCNH2 Q12809 2/20 0.44
▸ TDP1 Q9NUW8 1/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ L3MBTL1 Q9Y468 3/20 0.39
▸ RAB9A P51151 4/20 0.38
▸ NPC1 O15118 3/20 0.38
▸ MAPK1 P28482 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ TP53 P04637 1/20 0.38
▸ PKM P14618 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ GLA P06280 1/20 0.38
▸ THRB P10828 1/20 0.38
▸ POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2642234 0.92 GCK (0.47) GCKHTTKCNH2SMN1; SMN2RAB9A
SCHEMBL27579947 0.91 GCK (0.43) GCKHTTNPSR1KCNH2TDP1
SCHEMBL2653752 0.90 GCK (0.50) GCKHTTNPSR1KCNH2SMN1; SMN2
SCHEMBL27578456 0.90 GCK (0.50) GCKHTTNPSR1KCNH2
SCHEMBL2642192 0.90 GCK (0.50) GCKHTTNPSR1KCNH2SMN1; SMN2
SCHEMBL28747106 0.85 GCK (0.43) GCKHTTNPSR1KCNH2SMN1; SMN2
SCHEMBL27557961 0.82 KCNH2 (0.45) GCKHTTNPSR1KCNH2SMN1; SMN2
SCHEMBL27557991 0.82 KCNH2 (0.45) GCKHTTNPSR1KCNH2
SCHEMBL2657030 0.82 GCK (0.67) GCKKCNH2MAPTRAB9ANPC1
SCHEMBL27616310 0.82 KCNH2 (0.47) GCKHTTNPSR1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1329386-C Substituted phenylacetamides and their use as glucokinase activators HOFFMANN LA ROCHE CO LTD (CH) 2007-08-01 — — CN claimed
CN-1649859-A Substituted phenylacetamides and their use as glucokinase activators HOFFMANN LA ROCHE (CH) 2005-08-03 — — CN claimed
CN-1329386-C Substituted phenylacetamides and their use as glucokinase activators HOFFMANN LA ROCHE CO LTD (CH) 2007-08-01 — — CN disclosed
CN-1649859-A Substituted phenylacetamides and their use as glucokinase activators HOFFMANN LA ROCHE (CH) 2005-08-03 — — CN disclosed
EP-1501815-A1 SUBSTITUTED PHENYLACETAMIDES AND THEIR USE AS GLUCOKINASE ACTIVATORS F. HOFFMANN-LA ROCHE AG (CH) 2005-02-02 — — EP disclosed
WO-2003095438-A9 SUBSTITUTED PHENYLACETAMIDES AND THEIR USE AS GLUCOKINASE ACTIVATORS HOFFMANN LA ROCHE (CH) 2004-12-23 — — WO disclosed
WO-2003095438-A1 SUBSTITUTED PHENYLACETAMIDES AND THEIR USE AS GLUCOKINASE ACTIVATORS F. HOFFMANN-LA ROCHE AG (CH) 2003-11-20 — — WO disclosed
Send feedback